BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Sao_Paulo
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0300
TZNAME:-03
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Vilnius
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Oslo
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Amsterdam
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Copenhagen
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Athens
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Istanbul
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
TZNAME:+03
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Lisbon
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260326
DTEND;VALUE=DATE:20260329
DTSTAMP:20260404T130014
CREATED:20251203T224008Z
LAST-MODIFIED:20251203T224023Z
UID:10000437-1774483200-1774742399@oncodaily.com
SUMMARY:Stereotactic Radiotherapy and Radiosurgery for Brain Metastases and Skull Base Lesions
DESCRIPTION:The ESTRO course on Stereotactic Radiotherapy and Radiosurgery for Brain Metastases and Skull Base Lesions will take place in Rome\, Italy\, from March 26–28\, 2026. \n`Directed by Maximilian Niyazi\, this course is designed to allow radiation oncologists\, medical physicists\, radiation therapists\, and other specialists to deepen their expertise and master advanced SRS/SRT techniques specifically for treating complex cases like brain metastases and skull base lesions\, with an emphasis on practical\, real-world clinical guidance. The early registration deadline for the course is January 7\, 2026.
URL:https://oncodaily.com/event/stereotactic-radiotherapy-421174
LOCATION:Ospedale Isola Tiberina – Gemelli Isola\, Via di Ponte Quattro Capi\, 39\, Rome\, Rome Metropolitan City\, 00186\, Italy
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/Image-9-3.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20260319T080000
DTEND;TZID=Europe/Madrid:20260321T170000
DTSTAMP:20260404T130014
CREATED:20250719T103826Z
LAST-MODIFIED:20250801T203138Z
UID:10000223-1773907200-1774112400@oncodaily.com
SUMMARY:The ICHNO 2026
DESCRIPTION:The ICHNO 2026\, the 10th International Congress on Innovative Approaches in Head and Neck Oncology\, will be held from 19–21 March 2026 in Seville\, Spain\, under the theme: “Driven by Biology\, Centred on the Person.”  \nThis unique event—jointly organized by ESTRO\, EHNS\, and ESMO—will bring together the full spectrum of multidisciplinary expertise to explore the latest advances in head and neck oncology\, grounded in biology and focused on the individual. \nWith global thought leaders\, impactful research\, and opportunities for meaningful dialogue\, ICHNO 2026 will be a vital platform for education\, exchange\, and collaboration. The Chairpersons of the 10th ICHNO Congress are Mererid Evans (ESTRO)\, Giovanni Succo (EHNS)\, and Yungan Tao (ESMO). \nMore posts featuring European Society for Radiotherapy and Oncology on OncoDaily.
URL:https://oncodaily.com/event/the-ichno-2026-332267
LOCATION:Fibes – Conference and Exhibition\, Ave. Alcalde Luis Uruñuela\, 1\, Seville\, 41020\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/08/IMG_7601.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20251023T080000
DTEND;TZID=Europe/Paris:20251024T170000
DTSTAMP:20260404T130014
CREATED:20250310T120138Z
LAST-MODIFIED:20250607T192648Z
UID:10000172-1761206400-1761325200@oncodaily.com
SUMMARY:The 8th ESTRO Physics Workshop 2025: Science in Development by ESTRO
DESCRIPTION:The 8th ESTRO Physics Workshop 2025: Science in Development by ESTRO will be held from October 23-24\, 2025 at Toulouse\, France. \nThe 8th ESTRO Physics Workshop 2025\, themed “Science in Development by ESTRO Value-driven Adaptation in Radiation Oncology\,” will focus on key topics in radiation oncology. Sessions will cover the implementation and development of spatially fractionated radiotherapy (SFRT)\, real-time lesion tracking\, 3D printing in radiation oncology\, and the use of probabilities for treatment prescription\, optimization\, and evaluation of radiation treatment plans. The workshop aims to advance the application of innovative techniques in clinical practice. \nEarly registration deadline: 17th September\, 2025. \nApplication Deadline: 4th June\, 2025.
URL:https://oncodaily.com/event/253280
LOCATION:Hotel Mercure Toulouse Centre Compans\, Boulevard Lascrosses\, 8 Esplanade Compans Caffarelli\, Toulouse\, 31000\, France
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/03/Gjqg0OyXgAAD-Z--e1741607975784.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Sao_Paulo:20250922T000000
DTEND;TZID=America/Sao_Paulo:20250926T000000
DTSTAMP:20260404T130014
CREATED:20241216T193501Z
LAST-MODIFIED:20250607T192540Z
UID:10000104-1758499200-1758844800@oncodaily.com
SUMMARY:The Advanced Skills in Modern Radiotherapy course by ESTRO
DESCRIPTION:The Advanced Skills in Modern Radiotherapy course by ESTRO will be held from 22-26 September 2024\, Vilnius\, Lithuania. \nThe course will offer an exceptional opportunity for professionals in radiation therapy to expand their knowledge and skills in the field of radiotherapy. It will be designed to foster continuous professional development and provide valuable networking opportunities. Attendees like Maryam Hazem and Katharina Stelzhammer\, who will come from different backgrounds and levels of experience\, will find it to be an enriching experience. The course’s interdisciplinary approach\, involving faculty from diverse professions\, will ensure a variety of perspectives\, making the learning process more dynamic and engaging. \nOne of the most interesting aspects of the course will be the diverse range of topics covered\, providing a comprehensive overview of modern radiotherapy challenges. Both Maryam and Katharina will appreciate the opportunity to engage in valuable discussions with professionals from around the world\, exchanging insights on treatment strategies and technologies. The course will combine theoretical and practical content\, including workshops and interactive presentations\, allowing participants to directly apply what they learn in clinical contexts. Maryam\, for example\, will be particularly interested in discussing surface-guided radiation therapy and deep inspiration breath-hold techniques\, as her department in Australia will be implementing them.
URL:https://oncodaily.com/event/206806
LOCATION:Vilnius\, Vilnius\, Lithuania
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/11/IMG_7006.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vilnius:20250828T080000
DTEND;TZID=Europe/Vilnius:20250831T170000
DTSTAMP:20260404T130014
CREATED:20250207T181724Z
LAST-MODIFIED:20250607T192840Z
UID:10000132-1756368000-1756659600@oncodaily.com
SUMMARY:The Research Course in Radiotherapy Physics by ESTRO
DESCRIPTION:The Research Course in Radiotherapy Physics by ESTRO will be held from August 28-31\, 2025 at Vilnius\, Lithuania. \nThe Research Course in Radiotherapy Physics by ESTRO is designed to help participants develop critical skills for conducting research and writing scientific papers in the field of radiotherapy. The course aims to enhance participants’ ability to evaluate and improve research projects\, considering factors such as novelty\, impact\, feasibility\, and risk. By the end of the course\, participants should be able to effectively discuss and refine their research ideas\, maximizing their scientific value. \nThe course content includes discussions on research projects submitted by participants\, allowing them to receive feedback and learn from both peers and expert faculty. Participants will gain insight into current trends in radiotherapy physics and explore research opportunities in related technical fields\, helping them build a foundation for successful research careers. \nSubmit your research proposal (750 words\, PDF) plus CV (500 words\, PDF) by 1 May 2025 to  (mailto:mhristova@estro.org).
URL:https://oncodaily.com/event/240161
LOCATION:Panorama hotel\, Seinų g. 4\, Vilnius\, Vilnius\, 01313\, Lithuania
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/02/GjB9uiUXcAAtyLd-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Oslo:20250621T090000
DTEND;TZID=Europe/Oslo:20250623T170000
DTSTAMP:20260404T130014
CREATED:20250113T172851Z
LAST-MODIFIED:20250607T193246Z
UID:10000118-1750496400-1750698000@oncodaily.com
SUMMARY:17th International Wolfsberg Meeting on Molecular Radiation Biology/Oncology by ESTRO
DESCRIPTION:The 17th International Wolfsberg Meeting on Molecular Radiation Biology/Oncology by ESTRO will be held from June 21-23\, 2025. \nThe 17th International Wolfsberg Meeting on Molecular Radiation Biology/Oncology 2025 will be held at Hurdalsjøen Hotel\, Norway\, offering a serene\, nature-surrounded setting similar to the previous Wolfsberg Castle. This high-profile event will cover four cutting-edge topics in molecular radiation biology and oncology. Here are the Sessions: \n\nSession I: DNA Repair (Saturday afternoon/evening)\nSession II: Intra- and Inter-cellular Signalling (Sunday morning)\nSession III: Microenvironment (Sunday afternoon)\nSession IV: Novel Therapies and Biomarkers (Monday morning)\n\nThe meeting aims to explore both basic mechanisms and clinical perspectives.
URL:https://oncodaily.com/event/222908
LOCATION:Hurdalsjøen Hotel\, Skredderbakkvegen 9\, 2090 Hurdal\, Hurdalsjøen\, Norway
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/11/IMG_7006.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20250616T080000
DTEND;TZID=Europe/Amsterdam:20250617T170000
DTSTAMP:20260404T130014
CREATED:20250205T175640Z
LAST-MODIFIED:20250607T193535Z
UID:10000130-1750060800-1750179600@oncodaily.com
SUMMARY:VMAT and TomoTherapy TBI\, TMI and TMLI by ESTRO
DESCRIPTION:VMAT and TomoTherapy TBI\, TMI and TMLI by ESTRO will be held from 16-17 June\, 2025 at Utrecht\, The Netherlands. \nThe Myeloablative Total Body Irradiation (TBI) symposium will feature international experts discussing the latest advancements in highly conformal radiotherapy techniques\, such as VMAT and TomoTherapy\, for haematopoietic stem cell transplantation (HSCT) conditioning. These techniques\, including Total Marrow Irradiation (TMI) and Total Marrow and Lymphoid Irradiation (TMLI)\, aim to optimize treatment outcomes while minimizing toxicity by targeting specific areas like the bone marrow and lymphoid volume. \nThe symposium will include breakout sessions focused on technical and clinical aspects of VMAT and TomoTherapy planning and treatment. It is aimed at radiation oncologists\, medical physicists\, radiotherapy technologists\, haematologists\, and others interested in TBI\, TMI\, or TMLI. \nRegistration is open.
URL:https://oncodaily.com/event/239062
LOCATION:Utrecht\, Utrecht\, Netherlands
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/02/Gi2qT_kW8AAwFwO-1-e1738778015736.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vilnius:20250615T080000
DTEND;TZID=Europe/Vilnius:20250619T170000
DTSTAMP:20260404T130014
CREATED:20250217T121708Z
LAST-MODIFIED:20250607T193522Z
UID:10000145-1749974400-1750352400@oncodaily.com
SUMMARY:Dose Modelling and Verification for External Beam Radiotherapy by ESTRO
DESCRIPTION:Dose Modelling and Verification for External Beam Radiotherapy by ESTRO will be held from June 15-19\, 2025 at Vilnius\, Lithuania. \nThe course is aimed at medical physicists and experienced dosimetrists with practical experience in radiotherapy physics and treatment planning systems. It focuses on reviewing external beam radiotherapy physics\, multi-source modeling\, and dose calculation algorithms. It covers commissioning treatment planning systems\, dosimetry equipment\, and dose verification methods for advanced external beam therapy. \nCourse content includes radiation transport physics\, Linac head design\, patient and phantom characterization\, kernel-based and Monte Carlo dose calculation\, and radiation detector systems for TPS commissioning. The course also includes monitor unit calculations\, commissioning and quality assurance of treatment planning systems\, plan QA\, and treatment verification using in-vivo dosimetry. \nEarly Registration deadline: 19 March 2025.
URL:https://oncodaily.com/event/244563
LOCATION:Panorama hotel\, Seinų g. 4\, Vilnius\, Vilnius\, 01313\, Lithuania
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/02/GkTKCowWwAAC1sv-e1740306940960.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Copenhagen:20250601T080000
DTEND;TZID=Europe/Copenhagen:20250603T170000
DTSTAMP:20260404T130014
CREATED:20250126T193338Z
LAST-MODIFIED:20250607T193445Z
UID:10000123-1748764800-1748970000@oncodaily.com
SUMMARY:Agora 2025: ESTRO Future Leaders Retreat
DESCRIPTION:Agora 2025: ESTRO Future Leaders Retreat will be held from June 1-3\, 2025. \nESTRO will introduce Agora 2025\, an initiative designed to support early-career radiotherapy professionals and help advance their careers in the field. Agora 2025 will offer a platform for emerging leaders to collaborate\, discuss the challenges in radiation oncology\, and ensure that diverse perspectives are included in these discussions. Participants will reflect on societal and health trends impacting the discipline. \nIn line with ESTRO’s goals\, the initiative will foster long-term involvement from these future leaders\, guiding them through a shared journey aimed at progressing radiotherapy over the next decade. Early-career professionals will be encouraged to bring their insights and leadership to help shape the field. \nApplications are nor open and the deadline is February 10\, 2025!
URL:https://oncodaily.com/event/232845
LOCATION:Copenhagen\, Denmark\, Copenhagen\, Denmark
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/11/IMG_7006.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20250519T000000
DTEND;TZID=Europe/Madrid:20250523T000000
DTSTAMP:20260404T130014
CREATED:20250131T121429Z
LAST-MODIFIED:20250607T193416Z
UID:10000126-1747612800-1747958400@oncodaily.com
SUMMARY:The Evidence-Based Radiation Oncology by ESTRO
DESCRIPTION:The Evidence-Based Radiation Oncology course\, hosted by ESTRO in Seville\, Spain\, from May 19-23\, 2025\, will focus on clinical research\, biomedical statistics\, and evidence-based radiotherapy. \nParticipants will learn the core concepts of evidence-based medicine and the methodologies behind clinical research. The course will cover radiation therapy advancements for major tumor sites like breast\, prostate\, lung\, and gynecological cancers\, as well as palliative radiation therapy. With a combination of lectures and case discussions\, the course will provide opportunities for participants to explore clinical scenarios in small groups and evaluate management options based on the latest research evidence. \n Early registration ends on February 19\, 2025.
URL:https://oncodaily.com/event/235635
LOCATION:Seville\, Seville\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/01/Gic0gfHXAAATCHu-e1738325237281.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250502
DTEND;VALUE=DATE:20250507
DTSTAMP:20260404T130014
CREATED:20241017T205444Z
LAST-MODIFIED:20250607T193623Z
UID:10000034-1746144000-1746575999@oncodaily.com
SUMMARY:ESTRO 2025: Your Ultimate Guide to the World’s Leading Radiation Oncology Congress
DESCRIPTION:ESTRO 2025 (European Society for Radiotherapy and Oncology) is the premier global event for radiation oncology professionals\, taking place from May 2-6\, 2025\, at the Messe Wien Exhibition & Congress Center in Vienna\, Austria. This prestigious congress brings together experts from around the world to discuss transformative innovations in radiotherapy\, explore the latest clinical research\, and foster collaborations to enhance multidisciplinary cancer care. Whether you’re a radiation oncologist\, physicist\, or researcher\, ESTRO 2025 provides unparalleled opportunities for networking\, education\, and professional growth\, offering specialized tracks for young professionals and showcasing the most cutting-edge radiotherapy technology. \nSubmit your abstract to present at the leading radiation oncology event and join the conversation about the future of cancer treatment. \nWhere is ESTRO 2025?\nESTRO 2025 is a major event in the field of radiation oncology. It will be held in Vienna\, Austria\, from May 2 to 6\, 2025\, at the Messe Wien Exhibition & Congress Center. This congress gathers the global radiation oncology community for five days of cutting-edge research\, collaboration\, and learning opportunities\, and will feature discussions\, sessions\, and presentations led by top experts in the field. \nImportant Dates for ESTRO 2025 Abstract Submissions\nAbstract Submission Opens: September 2\, 2024\nAbstract Submission Deadline: November 20\, 2024\nLate-Breaking Abstract Deadline: March 19\, 2025\nAcceptance Notification: Mid-February 2025 \nAll abstracts are peer-reviewed\, and the best submissions will be celebrated in dedicated sessions\, including a joint session with The Lancet Oncology and Radiotherapy & Oncology (The Green Journal). Don’t miss your chance to be part of the most prestigious congress in the field. \n \nWho are the Key People at ESTRO 2025?\nThe Scientific Programme Committee is chaired by Matthias Guckenberger (CH)\, the ESTRO 2025 Chair and President. Other leaders include: \n\nFrank-André Siebert (DE)\, Chair of Brachytherapy\nIcro Meattini (IT)\, Chair of Clinical Radiotherapy\nChristian Richter (DE)\, Chair of Radiation Physics\nMonica Mangoni (IT)\, Chair of Radiobiology\nMaeve Kearney (IE)\, Chair of Radiation Therapy\n\nThe programme also includes special Young Track chairs\, Dylan Callens (BE) and Daniel Portik (RO)\, who focus on supporting those starting out in radiation oncology. \nWhat Sessions Will Be Held at ESTRO 2025?\nESTRO 2025’s programme theme is Transformative Innovation Through Partnership. The congress will cover a variety of disciplines with a focus on multidisciplinary cancer care. The Young Track offers educational sessions specifically designed for professionals at the early stages of their careers. Other sessions include: \n\nPanel discussions\nPitch sessions\nDebates\nSymposia\nTeaching lectures\n\nJoint sessions with partner associations are also included\, giving delegates access to a broader community. The congress will showcase the latest clinical trials\, cutting-edge research\, and technological advances. \nWhat is the Venue for ESTRO 2025?\nThe congress will take place at the Messe Wien Exhibition & Congress Center in Vienna\, Austria. This state-of-the-art venue will also host Europe’s largest industry exhibition in radiation oncology\, offering unparalleled opportunities to network with industry leaders and explore the latest innovations in the field. \n \nWhat is the Cost of Attending ESTRO 2025?\nESTRO members enjoy a reduced registration fee. Early bird rates are available until January 22\, 2025. Special rates are also offered for students and participants from emerging countries. To register as a student\, you must be an ESTRO member and provide a valid student card. All participants need to register using an individual email address to receive their unique login details for the ESTRO 2025 apps. \n \nsource: ESTRO.org \nWhat Are the Benefits of Submitting an Abstract to ESTRO 2025?\nSubmitting an abstract to ESTRO 2025 gives you the opportunity to: \n\nPresent your research at the leading radiation oncology congress.\nGain visibility through mini-oral sessions and poster discussions.\nHave your work considered for joint publication in Radiotherapy & Oncology or The Lancet Oncology.\nEngage with experts and peers through interactive sessions and debates.\n\nHow Can You Register for ESTRO 2025?\nYou can register online on the ESTRO website\, with secure payment options available via credit or debit card. For group registration\, you can contact the ESTRO office directly for support. \nWhat Opportunities Are Available for Young Professionals at ESTRO 2025?\nESTRO 2025 places a strong emphasis on nurturing the next generation of radiation oncology professionals through its dedicated Young Track. This track is specifically designed for those in the early stages of their careers\, offering tailored educational sessions\, networking opportunities\, and mentorship from leaders in the field. The Young Track chairs\, Dylan Callens (BE) and Daniel Portik (RO)\, ensure that young professionals have access to high-quality learning experiences\, including hands-on workshops\, pitch sessions\, and debates. These sessions provide invaluable insights and practical knowledge to help young professionals excel in the fast-evolving field of radiation oncology. \nWhat Should You Know About ESTRO 2025 Media and Communication Policies?\nESTRO welcomes media professionals to the congress. Press registration is free for journalists\, and embargoes for abstract reporting are lifted one month before the congress. For social media\, the official hashtag is #ESTRO25\, and participants are encouraged to share their experiences while respecting intellectual property and privacy guidelines. \nWhy Should You Attend ESTRO 2025?\nESTRO 2025 is the key event for radiation oncology professionals. It offers a platform for learning\, networking\, and innovation\, with a special focus on breakthrough research\, partnerships\, and technological advances in the field. Whether you’re early in your career or an experienced professional\, the congress provides something for everyone\, from interactive sessions to industry exhibitions. \n \nWhere Is ESTRO 2025 Held?\nESTRO 2025 will be hosted at the Messe Wien Exhibition & Congress Center in Vienna\, Austria. This modern venue offers state-of-the-art facilities\, ensuring a comfortable and efficient environment for both the congress and the large-scale industry exhibition. The center is located in the heart of Vienna\, easily accessible by public transport\, and provides all the amenities required for a successful international event. \nDiscover Vienna: The City of Culture and History\nVienna\, Austria’s capital\, is renowned for its rich cultural heritage\, stunning architecture\, and vibrant arts scene. From the historic Hofburg Palace to the majestic St. Stephen’s Cathedral\, the city is full of iconic landmarks that reflect its imperial past. As a hub of classical music\, you can visit famous sites such as the Vienna State Opera or explore the works of Mozart\, Beethoven\, and Strauss in the city’s many museums and concert halls. \nWhat Are the Top Hotels Near the ESTRO 2025 Venue?\n\nHilton Vienna Danube Waterfront – Located along the river\, this hotel offers beautiful views\, spacious rooms\, and easy access to the congress venue.\nHotel Messe Prater Wien – Just a few minutes’ walk from Messe Wien\, this modern hotel provides comfort and convenience.\nAustria Trend Hotel Messe Wien – This hotel offers contemporary accommodations right next to the congress center.\nMotel One Wien-Prater – Known for its stylish yet affordable rooms\, this hotel is a popular choice for travelers on a budget\, with close proximity to the venue.\n\nWhere to Go: Top Bars in Vienna\n\nKleinod – A stylish cocktail bar offering a wide range of creative drinks in an intimate atmosphere.\nLoos American Bar – Designed by the famous architect Adolf Loos\, this small bar is a hidden gem\, perfect for sipping a well-crafted cocktail.\nIf Dogs Run Free – A trendy\, laid-back bar with an impressive cocktail menu and a cool\, industrial vibe.\nThe Sign Lounge – Known for its innovative and visually stunning cocktails\, this bar is a must-visit for mixology enthusiasts.\n\nWhere to Eat: Top Restaurants in Vienna\n\nSteirereck – A Michelin-starred restaurant offering modern Austrian cuisine with an emphasis on fresh\, local ingredients.\nFiglmüller – Famous for serving one of the best Wiener Schnitzels in Vienna\, this traditional eatery is a must-try for local flavors.\nPlachutta – Known for its Tafelspitz (boiled beef)\, this restaurant is perfect for those looking to experience authentic Austrian cuisine.\nFabios – A sleek and upscale restaurant offering a mix of Mediterranean and Austrian dishes in a chic\, modern setting.\n\nPractical Tips for ESTRO 2025 Participants\n\nPublic Transport: Vienna boasts a highly efficient public transportation system\, including the U-Bahn (subway)\, trams\, and buses. A great option for visitors is the Vienna City Card\, which offers unlimited travel on public transport and discounts at numerous museums and attractions.\nVienna International Airport (VIE): The airport is well-connected to the city center via the City Airport Train (CAT)\, which takes only 16 minutes\, and by buses. Both options provide a smooth and quick journey to your accommodation or the congress venue.\nWeather: In early May\, Vienna experiences mild spring weather. Expect temperatures ranging from 12°C to 20°C (54°F to 68°F). It’s advisable to bring a light jacket or layers\, as evenings can be cooler.\nCurrency: Vienna uses the Euro (€). Credit cards are widely accepted\, but it’s always handy to have some cash for smaller establishments or public transport tickets.\nLanguage: German is the official language\, but most people in Vienna\, especially in tourist areas\, speak English.\n\nRead More About ESTRO
URL:https://oncodaily.com/event/estro-2025-2
LOCATION:Messe Wien Exhibition & Congress Center\, Vienna\, Austria
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2024/10/Daily.zip-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Athens:20250406T080000
DTEND;TZID=Europe/Athens:20250409T170000
DTSTAMP:20260404T130014
CREATED:20250310T121418Z
LAST-MODIFIED:20250607T194756Z
UID:10000171-1743926400-1744218000@oncodaily.com
SUMMARY:Comprehensive Quality Management in Radiotherapy: Quality Assessment and Improvement by ESTRO
DESCRIPTION:Comprehensive Quality Management in Radiotherapy: Quality Assessment and Improvement by ESTRO will be held from April 6-9\, 2025 at Athens\, Greece. \nThe “Comprehensive Quality Management in Radiotherapy: Quality Assessment and Improvement” course\, organized by ESTRO\, is designed for radiation oncologists\, medical physicists\, radiation therapists\, and hospital administrators. The course emphasizes the importance of quality in radiotherapy\, offering practical strategies to set up effective quality systems\, define key indicators\, and enhance patient safety and treatment efficiency. Aimed at leaders and future leaders\, the course aims to foster a culture of quality in radiotherapy departments and increase the number of quality champions within the field.
URL:https://oncodaily.com/event/253256
LOCATION:Titania Hotel Athens\, 52\, Panepistimiou\, Athens\, 10678\, Greece
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/11/IMG_7006.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Istanbul:20250403T090000
DTEND;TZID=Europe/Istanbul:20250406T123000
DTSTAMP:20260404T130014
CREATED:20250217T111741Z
LAST-MODIFIED:20250607T194819Z
UID:10000142-1743670800-1743942600@oncodaily.com
SUMMARY:Multidisciplinary Management of Breast Cancer by ESTRO
DESCRIPTION:Multidisciplinary Management of Breast Cancer by ESTRO will be held from April 03-06\, 2025 at Istanbul\, Turkey and Virtually. \nThis course is designed for specialists and trainees in radiation and clinical oncology\, including doctors\, physicists\, radiation therapists\, breast nurses\, and researchers\, with an interest in advancing their knowledge of breast cancer management. It encourages a multidisciplinary approach to treatment\, focusing on personalized care based on clinical presentation\, prognostic factors\, and patient needs\, while emphasizing shared decision-making. \nBy the end of the course\, participants will be able to understand the epidemiology\, clinical\, and biological aspects of breast cancer\, recognize different prognostic factors and tumor subtypes\, and interpret multimodality treatment results. Topics include primary and axillary surgery\, modern radiation therapy techniques\, re-irradiation\, fractionation schedules\, emerging treatments like particle therapy\, interactions between systemic treatment and radiation\, and the management of DCIS and locally advanced disease.
URL:https://oncodaily.com/event/244516
LOCATION:Radisson Blu Hotel Istanbul Sisli\, 19 Mayis Caddesi\, Istanbul\, 34360\, Turkey
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/IMG_1156.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Sao_Paulo:20250323T100000
DTEND;TZID=America/Sao_Paulo:20250327T123000
DTSTAMP:20260404T130014
CREATED:20241211T134319Z
LAST-MODIFIED:20250607T194912Z
UID:10000101-1742724000-1743078600@oncodaily.com
SUMMARY:The ESTRO Particle Therapy Course
DESCRIPTION:The ESTRO Particle Therapy Course will be held from March 23-27\, 2025 at Maastricht\, The Netherlands. \nThis course is designed for radiation oncologists\, medical physicists\, and professionals in related fields\, including trainees\, who are interested in particle therapy. It is aimed at individuals with a basic understanding of radiation oncology and radiation physics. Participants who are currently involved in clinical particle therapy projects\, practice particle therapy\, or wish to update their knowledge in this area will benefit from the course. The content covers fundamental and advanced topics in particle therapy\, equipping participants with the necessary knowledge to enhance their expertise and practice in this specialized field of radiation treatment. \n\n\n\n\nA key part of the program includes guidance on how to develop a particle therapy facility\, from project planning to starting clinical operations\, as well as expanding existing radiotherapy departments to include particle therapy. A guided tour of a local particle therapy facility will provide a real-world perspective on the implementation of the techniques discussed. Participants are required to have a basic understanding of radiobiology\, radiation physics\, and radiotherapy planning before attending the course. \n\n\n\n\nEarly date for Registration is January 10. \n 
URL:https://oncodaily.com/event/202007
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/12/Untitled-1-Recovered-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250320T180000
DTEND;TZID=America/Halifax:20250320T200000
DTSTAMP:20260404T130014
CREATED:20250224T105805Z
LAST-MODIFIED:20250607T195001Z
UID:10000141-1742493600-1742500800@oncodaily.com
SUMMARY:Falcon Workshop on Prostate SBRT by ESTRO
DESCRIPTION:Falcon Workshop on Prostate SBRT by ESTRO will be held at March 20 and 27\, 2025\, Virtually. \nThis workshop is aimed at those involved in prostate radiotherapy contouring\, including trainee oncologists\, established oncologists\, and contouring radiographers. It focuses on improving contouring accuracy\, a key source of error in radiotherapy. The course includes practical contouring exercises\, feedback from experts\, and guidance on common pitfalls\, with examples from the PACE trial’s quality assurance process. \nParticipants will complete pre-workshop homework and attend two online sessions. In the first\, faculty will present guidelines and review initial contours\, while in the second\, revised contours will be compared to reference contours with feedback provided. CME accreditation is being applied for through EACCME\, with credits recognized by the American Medical Association.
URL:https://oncodaily.com/event/244511
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/02/download-1-1-e1739789571286.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Lisbon:20250308T130000
DTEND;TZID=Europe/Lisbon:20250311T123000
DTSTAMP:20260404T130014
CREATED:20250216T125510Z
LAST-MODIFIED:20250607T195026Z
UID:10000140-1741438800-1741696200@oncodaily.com
SUMMARY:Upper GI: Technical and Clinical challenges for Radiation Oncologists by ESTRO
DESCRIPTION:Upper GI: Technical and Clinical challenges for Radiation Oncologists by ESTRO will be held from 8-10 March\, 2025 at Lisbon\, Portugal. \nThe Upper GI: Technical and Clinical Challenges for Radiation Oncologists course focuses on addressing the evolving role of radiotherapy in the treatment of upper gastrointestinal (GI) tumors\, which are known for their unfavorable prognosis. Despite these challenges\, there is significant potential for improvement through technological innovations and a multidisciplinary approach. \nThe course provides an interactive educational environment where participants can engage in peer reviews at each stage of radiation therapy practice\, including indication\, prescription\, delineation\, planning\, IGRT\, and outcome evaluation. The course incorporates the latest state-of-the-art technologies and knowledge while considering the perspectives of clinicians\, physicists\, and radiation therapy technologists (RTTs). \nSpecialists from various disciplines will guide participants in understanding the clinical\, anatomic\, and pathological aspects of upper GI tumors\, as well as the therapeutic advancements required for optimal radiation oncology practice. By the end of the course\, participants will be equipped to appropriately indicate radiation therapy\, prescribe treatments\, tailor delineation based on tumor location and stage\, optimize dose distribution\, utilize IGRT technologies effectively\, and monitor tumor response and control.
URL:https://oncodaily.com/event/244316
LOCATION:Jupiter Hotel\, Avenida da Republica\, 46\, Lisbon\, 1050-195\, Portugal
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/02/GkOE8qhWoAAsva4-e1740307240872.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250301T000000
DTEND;TZID=America/Halifax:20250305T000000
DTSTAMP:20260404T130014
CREATED:20241208T200313Z
LAST-MODIFIED:20250608T090016Z
UID:10000097-1740787200-1741132800@oncodaily.com
SUMMARY:The Nordic Radiotherapy Diploma Programme (NORTHDIP) for Clinical Oncologists by ESTRO
DESCRIPTION:The Nordic Radiotherapy Diploma Programme (NORTHDIP) for Clinical Oncologists by ESTRO will be going on for two years from March 2025 to November 2026. \nThe Nordic Radiotherapy Diploma Programme (NORTHDIP) is a two-year advanced education initiative designed for clinical oncologists across the Nordic countries: Denmark\, Iceland\, Finland\, Norway\, and Sweden. The programme addresses the need for supplementary radiotherapy training for oncologists who specialize in radiotherapy after their clinical oncology education. \nThe goal of NORTHDIP is to enhance radiotherapy skills and foster collaboration among Nordic clinical oncologists\, ultimately advancing expertise in the region and promoting collaborative research and development in radiotherapy. \nThe programme’s content is aligned with ESTRO’s core curriculum for radiation oncologists and covers a variety of advanced topics: \n\nSweden 2024: Advanced radiophysics\, dose planning\, organs-at-risk constraints\, and advanced technologies.\nNorway 2025: Radiobiology\, benign diseases\, and palliative care.\nFinland 2025: Reirradiation\, stereotactic radiotherapy\, and BNCT (Boron Neutron Capture Therapy).\nDenmark 2026: Adaptive radiotherapy and imaging (CBCT\, dual-energy CT\, PET-CT\, MRI)\, including the integration of proton and MR-Linac therapy.\nIceland 2026: Nordic research protocols\, including the design of clinical trials for collaborative Nordic implementation and shared patient recruitment.
URL:https://oncodaily.com/event/200355
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/11/IMG_7006.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20241107T080000
DTEND;TZID=Europe/Helsinki:20241110T170000
DTSTAMP:20260404T130014
CREATED:20241029T192326Z
LAST-MODIFIED:20250608T081133Z
UID:10000064-1730966400-1731258000@oncodaily.com
SUMMARY:16th European Multidisciplinary Congress on Urological Cancers EMUC 2024
DESCRIPTION:16th European Multidisciplinary Congress on Urological Cancers EMUC 2024 will take place in Lisbon\, Portugal\, from 7 to 10 November 2024. \nTop experts in medical oncology\, pathology\, radiation oncology\, radiology\, nuclear medicine\, and urology gathered at the EMUC24 congress from 7 to 10 November 2024 to share insights on best practices\, major trial developments\, and breakthroughs. \nThe scientific programme featured in-depth lectures\, practical hands-on courses\, and dynamic multidisciplinary case discussions. EMUC24 highlighted cutting-edge therapies\, current practices\, controversies\, and emerging technologies in GU cancer treatment. \nThis multidisciplinary approach was achieved through collaboration with the European Society for Medical Oncology (ESMO)\, the European Society for Radiotherapy and Oncology (ESTRO)\, and the European Association of Urology (EAU)\, alongside contributions from the Kidney Cancer Association (KCA) on recent kidney cancer advancements.
URL:https://oncodaily.com/event/174661
LOCATION:Lisbon Congress Centre\, Praça das Indústrias 1\, Lisbon\, 1300-307\, Portugal
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/Esmou.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
END:VCALENDAR